Logo image of EXJ.DE

READCREST CAPITAL AG (EXJ.DE) Stock Fundamental Analysis

Europe - FRA:EXJ - DE000A1E89S5 - Common Stock

1.35 EUR
-0.05 (-3.57%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to EXJ. EXJ was compared to 65 industry peers in the Media industry. EXJ has a bad profitability rating. Also its financial health evaluation is rather negative. EXJ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EXJ had negative earnings in the past year.
EXJ had a negative operating cash flow in the past year.
In the past 5 years EXJ always reported negative net income.
In the past 5 years EXJ always reported negative operating cash flow.
EXJ.DE Yearly Net Income VS EBIT VS OCF VS FCFEXJ.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -50K -100K -150K -200K -250K

1.2 Ratios

With a Return On Assets value of -38.90%, EXJ is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -38.9%
ROE N/A
ROIC N/A
ROA(3y)-37.78%
ROA(5y)-57.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EXJ.DE Yearly ROA, ROE, ROICEXJ.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EXJ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EXJ.DE Yearly Profit, Operating, Gross MarginsEXJ.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for EXJ remains at a similar level compared to 1 year ago.
There is no outstanding debt for EXJ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EXJ.DE Yearly Shares OutstandingEXJ.DE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 1M 2M 3M
EXJ.DE Yearly Total Debt VS Total AssetsEXJ.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100K 200K 300K 400K

2.2 Solvency

EXJ has an Altman-Z score of -7.13. This is a bad value and indicates that EXJ is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of EXJ (-7.13) is worse than 90.77% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.13
ROIC/WACCN/A
WACCN/A
EXJ.DE Yearly LT Debt VS Equity VS FCFEXJ.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 -50K -100K -150K -200K -250K

2.3 Liquidity

EXJ has a Current Ratio of 0.25. This is a bad value and indicates that EXJ is not financially healthy enough and could expect problems in meeting its short term obligations.
EXJ has a Current ratio of 0.25. This is amonst the worse of the industry: EXJ underperforms 89.23% of its industry peers.
A Quick Ratio of 0.25 indicates that EXJ may have some problems paying its short term obligations.
EXJ has a worse Quick ratio (0.25) than 87.69% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25
EXJ.DE Yearly Current Assets VS Current LiabilitesEXJ.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100K 200K 300K

More info and screens

0

3. Growth

3.1 Past

EXJ shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.75%.
EPS 1Y (TTM)-0.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.83%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXJ. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EXJ.DE Price Earnings VS Forward Price EarningsEXJ.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EXJ.DE Per share dataEXJ.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.02 -0.04 -0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EXJ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

READCREST CAPITAL AG

FRA:EXJ (9/12/2025, 7:00:00 PM)

1.35

-0.05 (-3.57%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)04-30 2025-04-30
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners41.29%
Ins Owner ChangeN/A
Market Cap4.46M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.9%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-37.78%
ROA(5y)-57.56%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z -7.13
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.83%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-128.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-128.07%
OCF growth 3YN/A
OCF growth 5YN/A